Trends of hepatitiS B notification rates in Turkey, 1990 TO 2012

Eurosurveillance

Volumn 18, Issue 47, 2013, Pages

  Ay, P ^a   Torunoglu, M A ^b   Com, S ^b   Cipil Z ^b   Mollahaliloglu S ^b   Erkoc Y ^b   Dilmen, U ^b  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b MINISTRY OF HEALTH   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIGEN; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONDOM USE; CONTROL STRATEGY; DISEASE TRANSMISSION; FEMALE; GEOGRAPHIC INFORMATION SYSTEM; HEALTH CARE PERSONNEL; HEALTH SURVEY; HEPATITIS B; HIGH RISK POPULATION; HUMAN; INFANT; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MANDATORY TESTING; MASS SCREENING; META ANALYSIS (TOPIC); PRESCHOOL CHILD; PREVALENCE; PREVENTIVE HEALTH SERVICE; PROSTITUTION; SCHOOL CHILD; SOCIOECONOMICS; TURKEY (REPUBLIC); VACCINATION;

EID: 84888092684     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2013.18.47.20636     Document Type: Article

References (34)

1. World Health Organization (WHO). Hepatitis B. Fact Sheet 204. Geneva: WHO; 2000. Available from:http://who.int/inf-fs/en/fact204.html
2. Hepatitis B vaccines. Wkly Epidemiol Rec. 2004;79(28):255-63. PMid:15344666.
3. The Global Alliance for Vaccines and Immunizations (GAVI). Hepatitis B Fact Sheet. Geneva: GAVI; 2005.
4. Deǧertekin H, Güneş G. Horizontal transmission of hepatitis B virus in Turkey. Public Health. 2008;122(12):1315-7. http://dx.doi.org/10.1016/j.puhe.2008.04.010 PMid:18752817
5. Toy M, Önder FO, Wörmann T, Bozdayi AM, Schalm SW, Borsboom GJ, et al. Age-and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review. BMC Infect Dis. 2011;11:337. http://dx.doi.org/10.1186/1471-2334-11-337 PMid:22151620 PMCid:PMC3262158
6. Mehmet D, Meliksah E, Serif Y, Gunay S, Tuncer O, Zeynep S. Prevalence of hepatitis B infection in the southeastern region of Turkey: comparison of risk factors for HBV infection in rural and urban areas. Jpn J Infect Dis. 2005;58(1):15-9. PMid:15728984
7. Yildirim B, Barut S, Bulut Y, Yenişehirli G, Ozdemir M, Cetin I, et al. Seroprevalence of hepatitis B and C viruses in the province of Tokat in the Black Sea region of Turkey: A population-based study. Turk J Gastroenterol. 2009;20(1):27-30. PMid:19330732
8. Karabay O, Serin E, Tamer A, Gökdoǧan F, Alpteker H, Ozcan A, et al. Hepatitis B carriage and Brucella seroprevalence in urban and rural areas of Bolu province of Turkey: a prospective epidemiologic study. Turk J Gastroenterol. 2004;15(1):11-3. PMid:15264115
9. Akcam FZ, Uskun E, Avsar K, Songur Y. Hepatitis B virus and hepatitis C virus seroprevalence in rural areas of the southwestern region of Turkey. Int J Infect Dis. 2009;13(2):274-84. http://dx.doi.org/10.1016/j.ijid.2008.07.005 PMid:18945630
10. Deǧertekin H, Tuzcu A, Yalçin K. Horizontal transmission of HBV infection among students in Turkey. Public Health. 2000;114(5):411-2. PMid:11035467
11. Kanra G, Tezcan S, Badur S, Turkish National Study Team. Hepatitis B and measles seroprevalence among Turkish children. Turk J Pediatr. 2005;47(2):105-10. PMid:16052847
12. Otkun M, Erdogan MS, Tatman-Otkun M, Akata F. Exposure time to hepatitis B virus and associated risk factors among children in Edirne, Turkey. Epidemiol Infect. 2005;133(3):509-16. http://dx.doi.org/10.1017/S0950268805003675 PMid:15962558 PMCid:PMC2870275
13. Badur S. Hepatit B infeksiyonlari{dotless}: Epidemiyoloji ve Aşi{dotless} [Hepatitis B Infections: Epidemiology and Vaccine]. Klinik Gelişim. 2005;18(3):32-43. Turkish.
14. Ertekin V, Selimoǧlu MA, Altinkaynak S. Sero-epidemiology of hepatitis B infection in an urban paediatric population in Turkey. Public Health. 2003;117(1):49-53. http://dx.doi.org/10.1016/S0033-3506(02)00018-5
15. Doganci T, Uysal G, Kir T, Bakirtas A, Kuyucu N, Doganci L. Horizontal transmission of hepatitis B virus in children with chronic hepatitis B. World J Gastroenterol. 2005;11(3):418-20. PMid:15637758
16. Ucmak H, Kokoglu OF, Celik M, Ergun UGO. Intra-familial spread of hepatitis B virus infection in eastern Turkey. Epidemiol Infect. 2007;135(8):1338-43. http://dx.doi.org/10.1017/S0950268807008011 PMid:17313693 PMCid:PMC2870700
17. General Directorate for Primary Health Care. Bulaşi{dotless}ci{dotless} Hastali{dotless}klari{dotless}n İhbari{dotless} ve Bildirim Sistemi: Standart Tani{dotless}, Sürveyans ve Bildirim Sistemi. [Standard Diagnosis, Surveillance and Laboratory Guideline for Communicable Diseases' Notification and Reporting System]. Ankara: Turkish Ministry of Health; 2004. Turkish.
18. Classification Sever. Ankara: TUIK Turkish Statistical Institute. [Accessed: 1 Sep 2012] Available from:http://tuikapp.tuik.gov.tr/DIESS/SiniflamaSurumDetayAction.do?surumId=164&turId=7&turAdi= 5. Geographical Classifications
19. Bulaşi{dotless}ci{dotless} Hastali{dotless}klari{dotless}n Bildirim Sistemi Yönergesi. 24.02.2004 tarih ve 1534 sayi{dotless}li{dotless} [Communicable disease notification system directive. No. 1534]. Ankara: Ministry of Health; 24 Feb 2004. Turkish. Available from:http://www.saglik.gov.tr/TR/belge/1-4005/bulasici-hastaliklarin-ihbari-ve-bildirim-sistemi-yoner-.html
20. Bulaşi{dotless}ci{dotless} Hastali{dotless}klari{dotless}n İhbari{dotless} ve Bildirim Sistemi Genelgesi 22.10.2004 tarih ve 129 sayi{dotless}li{dotless} [Communicable Disease Notification System Circular. No. 129]. Ankara: Ministry of Health; 22 Oct 2004. Turkish. Available from:https://www.google.com.tr/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CCsQFjAA&url=http%3A%2F%2Fwww.saglik.gov.tr%2FASHGM%2Fdosya%2F1-12244%2Fh%2Fbulasicihbargenelge.doc&ei=kbmIUqmtE8_Kswb454DQCg&usg=AFQjCNE3WzQXP5QY9WK6g_4OBwZTb0BWjg
21. Erden S, Büyüköztürk S, Calangu S, Yilmaz G, Palanduz S, Badur S. A study of serological markers of hepatitis B and C viruses in Istanbul, Turkey. Med Princ Pract. 2003;12(3):184-8. http://dx.doi.org/10.1159/000070757 PMid:12766338
22. Stroffolini T, Mele A, Tosti ME, Gallo G, Balocchini E, Ragni P, et al. The impact of the hepatitis B mass immunisation campaign on the notification and risk factors of acute hepatitis B in Italy. J Hepatol. 2000;33(6):980-5. http://dx.doi.org/10.1016/S0168-8278(00)80132-4
23. Mele A, Tosti ME, Mariano A, Pizzuti R, Ferro A, Borrini B, et al. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Clin Infect Dis. 2008;46(6):868-75. http://dx.doi.org/10.1086/528687 PMid:18269332
24. La Torre G, Nicolotti N, de Waure C, Chiaradia G, Specchia ML, Mannocci A, et al. An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy. Virol J. 2008;5:84. http://dx.doi.org/10.1186/1743-422X-5-84 PMid:18652653 PMCid:PMC2517063
25. D'Argenio P, Esposito D, Mele A, Ortolani G, Adamo B, Rapicetta M, et al. Decline in the exposure to hepatitis A and B infections in children in Naples, Italy. Public Health. 1989;103(5):385-9. http://dx.doi.org/10.1016/S0033-3506(89)80009-5
26. Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep. 2006;55(RR-16):1-33. PMid:17159833
27. Demirtürk N, Demirdal T, Toprak D, Altindis M, Aktepe OC. Hepatitis B and C virus in West-Central Turkey: seroprevalence in healthy individuals admitted to a university hospital for routine health checks. Turk J Gastroenterol. 2006;17(4):267-72. PMid:17205404
28. Emiroglu HH, Altunay H, Oguz S. Prevalence of hepatitis B virus carriers among soldiers and civilians in Turkey. J Clin Gastroenterol. 2004;38(7):614-5. http://dx.doi.org/10.1097/00004836-200408000-00018 PMid:15232371
29. Khan F, Shams S, Qureshi ID, Israr M, Khan H, Sarwar MT, et al. Hepatitis B virus infection among different sex and age groups in Pakistani Punjab. Virol J. 2011;8:225 http://dx.doi.org/10.1186/1743-422X-8-225 PMid:21569532 PMCid:PMC3118204
30. European Centre for Disease Prevention and Control (ECDC). Annual Epidemiological Report 2012. Reporting on 2010 surveillance data and 2011 epidemic intelligence data. Stockholm: ECDC; 2013. Available from:http://ecdc.europa.eu/en/publications/_layouts/forms/Publication_DispForm.aspx?ID=753&List=4f55ad51-4aed-4d32-b960-af70113dbb90
31. Durusoy R, Karababa AO. Completeness of hepatitis, brucellosis, syphilis, measles and HIV/AIDS surveillance in Izmir, Turkey. BMC Public Health. 2010;10:71. http://dx.doi.org/10.1186/1471-2458-10-71 PMid:20158922 PMCid:PMC2834629
32. Pitigoi D, Rafila A, Pistol A, Arama V, Molagic V, Streinu-Cercel A. Trends in hepatitis B notification in Romania, 1989-2005. Euro Surveill. 2008;13(2):pii=8012. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=8012. PMid:18445385
33. Salleras L, Dominguez A, Bruguera M, Carde-osa N, Batalla J, Carmona G, et al. Dramatic decline in acute hepatitis B infection and disease notification rates among adolescents and young people after 12 years of a mass hepatitis B vaccination programme of pre-adolescents in the schools of Catalonia (Spain). Vaccine. 2005;23(17-18):2181-4. http://dx.doi.org/10.1016/j.vaccine.2005.01.068 PMid:15755591
34. Hong Z, Smart G, Zaniewski G, Wu H, Wu J, Goedhuis N, et al. Epidemiological study of hepatitis B virus infection in Manitoba, Canada, 1992-2003. Eur J ClinMicrobiol Infect Dis. 2005;24(7):464-70. http://dx.doi.org/10.1007/s10096-005-1350-6 PMid:15959814